510(k) K230236

Lyra Influenza A+B Assay by Quidel Corporation — Product Code OZE

K230236 is an FDA 510(k) premarket notification submitted by Quidel Corporation for the device "Lyra Influenza A+B Assay". The FDA issued a decision of Substantially Equivalent on Mar 3, 2023. The device falls under product code OZE (Influenza A And Influenza B Multiplex Nucleic Acid Assay), a Class II device regulated under 21 CFR 866.3980. Quidel Corporation has 36 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 3, 2023
Date Received
Jan 30, 2023
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Influenza A And Influenza B Multiplex Nucleic Acid Assay
Device Class
Class II
Regulation Number
866.3980
Review Panel
MI
Submission Type
510(k)

An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of influenza A and B nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract influenza viral infections if used in conjunction with other clinical and laboratory findings.

Need the full FDA record for Quidel Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K230236. Report a data issue: hello@regdatalab.com.